Hyaluronan activates mitogen-activated protein kinase via Ras-signaling pathway

International Journal of Oncology

Volumn 14, Issue 4, 1999, Pages 733-738

  Serbulea, Mihaela ^a   Kakumu, Shinichi ^b   Thant, Aye Aye ^a   Miyazaki, Kou ^a   Machida, Kazuya ^a   Senga, Takeshi ^a   Ohta, Seiji ^a   Yoshioka, Kentaroh ^a   Hotta, Nigishi ^a   Hamaguchi, Michinari ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Hyaluronan; Mitogen activatcd protein kinase; Ras; Signal transduction; Tyrosine phosphorylation

Indexed keywords

HYALURONIC ACID; IMMUNOLOGICAL ADJUVANT; PROTEIN KINASE (CALCIUM,CALMODULIN); RAS PROTEIN; TYROSINE;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIVISION; DRUG EFFECT; ENZYME ACTIVATION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; CELLS, CULTURED; ENZYME ACTIVATION; HYALURONIC ACID; PHOSPHORYLATION; RAS PROTEINS; RATS; SIGNAL TRANSDUCTION; TYROSINE;

EID: 0033113869     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.4.733     Document Type: Article

References (30)

1. Laurent TC and Fraser JRE: Hyaluronan. FASEB J 6: 2397-2404, 1992.
2. Turley EA: Hyaluronan and cell locomotion. Cancer Metastasis Rev 11: 21-30, 1992.
3. Lokeshwar VB, Oebek C, Soloway MS and Block NL: Tumor-associated Hyaluronic Acid: a new sensitive and specific urine marker for bladder cancer. Cancer Res 57: 773-777, 1997.
4. Lokeshwar VB, Lokeshwar BL, Pham HT and Block NL: Association of elevated levels of Hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Res 56: 651-657, 1996.
5. Miyasaka M: Cancer metastasis and adhesion molecules. Clin Orthop 312: 10-18, 1995.
6. Sy MS, Guo Y-J and Stamenkovic I: Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 174: 859-866, 1991.
7. Bartolazzi A, Peach R, Aruffo A and Stamenkovic I: Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 180: 53-66, 1994.
8. Asher R and Bignami A: Hyaluronate binding and CD44 expression in human glioblastoma cells and astrocytes. Exp Cell Res 203: 80-90, 1992.
9. Merzak A, Koocheckpour S and Pilkington GJ: CD44 mediates human glioma cells adhesion and invasion in vitro. Cancer Res 54: 3988-3992, 1992.
10. Toole BP and Whelan J (eds): The role and regulation of tumor-associated hyaluronan. In: The Biology of Hyaluronan. Wiley, Chichester Ciba Foundation Symposium, New York, pp150-169, 1989.
11. Ohta S, Yoshida J, Iwata H and Hamaguchi M: Hyaluronate activates tyrosine phosphorylation of cellular proteins including focal adhesion kinase via CD44 in human glioma cells. Int J Oncol 10: 561-564, 1997.
12. c-src is required for cell locomotion regulated by the hyaluronan receptor RHAMM. Oncogene 13: 2213-2224, 1996.
13. Nishida E and Gotoh Y: The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci 18: 128-131, 1993.
14. Blenis J: Signal transduction via the MAP kinases: Proceed at your own RSK. Proc Natl Acad Sci USA 90: 5889-5892, 1993.
15. Marshall CJ: Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Curr Opin Genet Dev 4: 82-89, 1994.
16. Seger R and Krebs EG: The MAPK signaling cascade. FASEB J 9: 726-735, 1995.
17. Feig LA and Cooper GM: Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol Cell Biol 8: 3235-3243, 1988.
18. Kawai S: Transformation of rat cells by fusion-infection with Rous sarcoma virus. J Virol 34: 772-776, 1980.
19. Hamaguchi M and Hanafusa H: Association of p60 src with Triton X-100-resistant cellular structure correlates with morphological transformation. Proc Natl Acad Sci USA 84: 2314-2316, 1987.
20. Thant AA, Serbulea M, Kikkawa F, Liu E, Tomotaka Y and Hamaguchi M: c-Ras is required for the activation of the matrix metalloproteinases by concavalin A in 3Y1 cells. FEBS Lett 406: 28-30, 1997.
21. Hamaguchi M, Grandori C and Hanafusa H: Phosphorylation of cellular proteins in Rous-sarcoma virus-infected cells: analysis by use of phosphotyrosine antibodies. Mol Cell Biol 8: 3035-3042, 1988.
22. v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system. EMBO J 12: 307-314, 1993.
23. Takeshima E, Hamaguchi M, Watanabe T, Akiyama S, Kataoka M, Ohnishi Y, Xiao H, Nagai Y and Takagi H: Abberant elevation of tyrosine specific phosphorylation in human gastric cancer cells. Jpn J Cancer Res 82: 1428-1435, 1991.
24. Papakonstantinou E, Karakiulakis G, Roth M and Block LH: Platelet-derived growth factor stimulates the secretion of hyaluronic acid by proliferating human vascular smooth muscle cells. Proc Natl Acad Sci USA 92: 9881-9885, 1995.
25. v-src with the cytoskeletal structure and with phosphatidylinositol 3′ kinase. Oncogene 8: 559-564, 1993.
26. Denizot F and Lang R: Rapid colorimetric assay for cell growth and survival. Modification to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89: 271-277, 1986.
27. Dent P, Haser W, Haystead TAJ, Vincent LA, Roberts TM and Sturgill TW: Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. Science 257: 1404-1407, 1992.
28. Howe LR, Leevers SJ, Gomez N, Nakielny S, Cohen P and Marshall CJ: Activation of the MAP kinase pathway by the protein kinase raf. Cell 71: 335-342, 1992.
29. Hughes DA, Ashworth A and Marshall CJ: Complementation of byr1 in fission yeast by mammalian MAP kinase kinase requires coexpression of Raf kinase. Nature 364: 349-352, 1993.
30. MacDonald SG, Crews CM, Wu L, Driller J, Clark R, Erikson RL and McCormick F: Reconstituition of the Raf-1-MEK-ERK signal transduction pathway in vitro. Mol Cell Biol 13: 6615-6620, 1993.